Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

MXenes in healthcare, synthesis, fundamentals and applications

  • Babar, Zaheer Ud Din|||0000-0003-3293-6244
  • Iannotti, Vincenzo|||0000-0001-7229-5045
  • Rosati, Giulio|||0000-0002-0227-4561
  • Zaheer, Ayesha|||0009-0006-7667-6308
  • Velotta, Raffaele|||0000-0003-1077-8353
  • Della Ventura, Bartolomeo|||0000-0003-2920-6187
  • Álvarez Diduk, Ruslan|||0000-0002-9876-1574
  • Merkoçi, Arben|||0000-0003-2486-8085
Since their discovery over a decade ago, MXenes have transformed the field of "materials for healthcare", stimulating growing interest in their healthcare-related applications. These developments have also driven significant advancements in MXenes' synthesis. This review systematically examines the synthesis of MXenes and their applications in sensing and biomedical fields, underscoring their pivotal role in addressing critical challenges in modern healthcare. We describe the experimental synthesis of MXenes by combining appropriate laboratory modules with the mechanistic principles underlying each synthesis step. In addition, we provide extensive details on the experimental parameters, critical considerations, and essential instructions for successful laboratory synthesis. Various healthcare applications including sensing, biomedical imaging, synergistic therapies, regenerative medicine, and wearable devices have been explored. We further highlight the emerging trends of MXenes, viz., their role as nanovehicles for drug delivery, vectors for gene therapy, and tools for immune profiling. By identifying the important parameters that define the utility of MXenes in biomedical applications, this review outlines strategies to regulate their biomedical profile, thereby serving as a valuable guide to design MXenes with application-specific properties. The final section integrates experimental research with theoretical studies to provide a comprehensive understanding of the field. It examines the role of emerging technologies, such as artificial intelligence (AI) and machine learning (ML), in accelerating material discovery, structure-property optimization, and automation. Complemented by detailed supplementary information on synthesis, stability, biocompatibility, environmental impact, and theoretical insights, this review offers a profound knowledge base for understanding this diverse family of 2D materials. Finally, we compared the potential of MXenes with that of other 2D materials to underscore the existing challenges and prioritize interdisciplinary collaboration. By synthesizing key studies from its discovery to current trends (especially from 2018 onward), this review provides a cohesive assessment of MXene synthesis with theoretical foundations and their prospects in the healthcare sector.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Harnessing bioluminescent bacteria to develop an enzymatic-free enzyme-linked immunosorbent assay for the detection of clinically relevant biomarkers

  • Hu, Liming
  • Rossetti, Marianna
  • Bergua, José Francisco
  • Parolo, Claudio
  • Álvarez-Diduk, Ruslan
  • Rivas, Lourdes
  • Idili, Andrea
  • Merkoçi, Arben
Enzyme-linked immunosorbent assay (ELISA) is the gold standard technique for measuring protein biomarkers due to its high sensitivity, specificity, and throughput. Despite its success, continuous advancements in ELISA and immunoassay formats are crucial to meet evolving global challenges and to address new analytical needs in diverse applications. To expand the capabilities and applications of immunoassays, we introduce a novel ELISA-like assay that we call Bioluminescent-bacteria-linked immunosorbent assay (BBLISA). BBLISA is an enzyme-free assay that utilizes the inner filter effect between the bioluminescent bacteriaAllivibrio fischeriand metallic nanoparticles (gold nanoparticles and gold iridium oxide nanoflowers) as molecular absorbers. Functionalizing these nanoparticles with antibodies induces their accumulation in wells upon binding to molecular targets, forming the classical immune-sandwich complex. Thanks to their ability to adsorb the light emitted by the bacteria, the nanoparticles can suppress the bioluminescence signal, allowing the rapid quantification of the target. To demonstrate the bioanalytical properties of the novel immunoassay platform, as a proof of principle, we detected two clinically relevant biomarkers (human immunoglobulin G and SARS-CoV-2 nucleoprotein) in human serum, achieving the same sensitivity and precision as the classic ELISA. We believe that BBLISA can be a promising alternative to the standard ELISA techniques, offering potential advancements in biomarker detection and analysis by combining nanomaterials with a low-cost, portable bioluminescent platform., We acknowledge Consejo Superior de Investigaciones Científicas (CSIC) for the project “COVID19-122”. TheMICROB-PREDICT project has received funding from theEuropean Union’s Horizon 2020 research and innovationprogramme under grant agreement no 881603. ICN2 is fundedby CERCA programme / Generalitat de Catalunya, and issupported by the Severo Ochoa Centres of Excellenceprogramme, Grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. L.H. acknowledges ChinaScholarship Council (no. 201808360196) and acknowledges Universitat Autonoma de Barcelona (UAB) for the possibilityof performing this work inside the framework of Biotechnology Ph.D. Programme. M.R. acknowledges the MSCA projectfunded the European Union’s Horizon 2020 research andinnovation programme under the Marie Sklodowska-Curiegrant agreement no 101029884. C.P. acknowledges supportfrom the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033, support from the Generalitat deCatalunya through the CERCA Program and support from theSpanish Ministry of Science and Innovation through theprogram PID2020-116770RJ-I00 and CPP2021-008658. TheICN2 is funded by the CERCA programme / Generalitat deCatalunya. The ICN2 is A.M. acknowledge Departament deRecerca i Universitats of Generalitat de Catalunya for the grant 2021 SGR 01464. This project has received funding from the European Union’s Horizon Europe − the Framework Programme for Research and Innovation (2021-2027) undergrant agreement No 101120706., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001214-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2018-000806-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Reduced graphene oxide electrodes meet lateral flow assays: A promising path to advanced point-of-care diagnostics

  • Calucho, Enric
  • Álvarez-Diduk, Ruslan
  • Piper, Andrew
  • Rossetti, Marianna
  • Nevanen, Tarja K.
  • Merkoçi, Arben
Research in electrochemical detection in lateral flow assays (LFAs) has gained significant momentum in recent years. The primary impetus for this surge in interest is the pursuit of achieving lower limits of detection, especially given that LFAs are the most widely employed point-of-care biosensors. Conventionally, the strategy for merging electrochemistry and LFAs has centered on the superposition of screen-printed electrodes onto nitrocellulose substrates during LFA fabrication. Nevertheless, this approach poses substantial limitations regarding scalability. In response, we have developed a novel method for the complete integration of reduced graphene oxide (rGO) electrodes into LFA strips. We employed a CO2 laser to concurrently reduce graphene oxide and pattern nitrocellulose, exposing its backing to create connection sites impervious to sample leakage. Subsequently, rGO and nitrocellulose were juxtaposed and introduced into a roll-to-roll system using a wax printer. The exerted pressure facilitated the transfer of rGO onto the nitrocellulose. We systematically evaluated several electrochemical strategies to harness the synergy between rGO and LFAs. While certain challenges persist, our rGO transfer technology presents compelling potential for setting a new standard in electrochemical LFA fabrication., This work has received funding from the European Union’s Horizon 2020 research and innovation programme under the Graphene Flagship grant agreement no. 881603. The support received is also acknowledged by R. Alvarez. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. The European Union cannot be held responsible for them. This project has received funding from the European Union’s Horizon Europe – the Framework Programme for Research and Innovation (2021–2027) under grant agreement No 101120706. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, Grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. E. Calucho acknowledges Ministerio de Ciencia e Innovación of Spain and Fondo Social Europeo for the Fellowship PRE2018-084856 awarded under the call “Ayudas para contratos predoctorales para la formación de doctors, Subprograma Estatal de Formación del Programa Estatal de Promoción del Talento y su Empleabilidad en I + D + i”, under the framework of “Plan Estatal de Investigación Científica y Técnica y de Innovación 2017–2020”. E. Calucho also acknowledges Universitat Autònoma de Barcelona (UAB) for the possibility of performing this work inside the framework of Biotechnology PhD Programme. M. Rossetti is supported from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101029884 (SERENA). We acknowledge Departament de Recerca i Universitats of Generalitat de Catalunya for the grant 2021 SGR 01464 and Grant PID2021-124795NB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe”., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MXenes in healthcare: synthesis, fundamentals and applications

  • Babar, Zaheer Ud Din
  • Iannotti, Vincenzo
  • Rosati, Giulio
  • Zaheer, Ayesha
  • Velotta, Raffaele
  • Della Ventura, Bartolomeo
  • Álvarez-Diduk, Ruslan
  • Merkoçi, Arben
Since their discovery over a decade ago, MXenes have transformed the field of "materials for healthcare", stimulating growing interest in their healthcare-related applications. These developments have also driven significant advancements in MXenes' synthesis. This review systematically examines the synthesis of MXenes and their applications in sensing and biomedical fields, underscoring their pivotal role in addressing critical challenges in modern healthcare. We describe the experimental synthesis of MXenes by combining appropriate laboratory modules with the mechanistic principles underlying each synthesis step. In addition, we provide extensive details on the experimental parameters, critical considerations, and essential instructions for successful laboratory synthesis. Various healthcare applications including sensing, biomedical imaging, synergistic therapies, regenerative medicine, and wearable devices have been explored. We further highlight the emerging trends of MXenes, viz., their role as nanovehicles for drug delivery, vectors for gene therapy, and tools for immune profiling. By identifying the important parameters that define the utility of MXenes in biomedical applications, this review outlines strategies to regulate their biomedical profile, thereby serving as a valuable guide to design MXenes with application-specific properties. The final section integrates experimental research with theoretical studies to provide a comprehensive understanding of the field. It examines the role of emerging technologies, such as artificial intelligence (AI) and machine learning (ML), in accelerating material discovery, structure-property optimization, and automation. Complemented by detailed supplementary information on synthesis, stability, biocompatibility, environmental impact, and theoretical insights, this review offers a profound knowledge base for understanding this diverse family of 2D materials. Finally, we compared the potential of MXenes with that of other 2D materials to underscore the existing challenges and prioritize interdisciplinary collaboration. By synthesizing key studies from its discovery to current trends (especially from 2018 onward), this review provides a cohesive assessment of MXene synthesis with theoretical foundations and their prospects in the healthcare sector., Zaheer Ud din Babar acknowledges Scuola Superiore Meridional (SSM), University of Naples, Federico-II, Naples, Italy, for funding his stay as a visiting PhD scholar at the Catala Institute of Nanoscience and Nanotechnology (ICN2), Campus UAB, 08193 Bellaterra, Barcelona, Spain. The authors are thankful to all individuals and/or organizations who provided permission to republish/reproduced their figures and other relevant information. This project has received funding from the European Union’s Horizon Europe – the Framework Programme for Research and Innovation (2021–2027) under grant agreement No 101120706. The views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, Grant CEX2021-001214-S, funded by MCIU/AEI/10.13039.501100011033. We acknowledge Departament de Recerca i Universitats of Generalitat de Catalunya for the grant 2021 SGR 01464. We also acknowledge grant PID2021-124795NB-I00 funded by MICIU/AEI/10.13039/ 501100011033 and by ‘‘ERDF/EU’’, With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Graphene Derivatives as Efficient Transducing Materials for Covalent Immobilization of Biocomponents in Electrochemical Biosensors

  • Jakubec, Petr
  • Panáček, David
  • Nalepa, Martin Alex
  • Rossetti, Marianna
  • Álvarez-Diduk, Ruslan
  • Merkoçi, Arben
  • Vasjari, Majlinda
  • Kulla, Lueda
  • Otyepka, Michal
This review highlights the role of graphene derivatives in advancing electrochemical biosensors for applications in diagnostics, environmental monitoring, and industrial sensing. Graphene derivatives, including graphene oxide (GO), reduced GO, and wide range of graphenes prepared via fluorographene chemistry, represent a prominent class of transducing materials in electrochemical biosensor development. Their ability to support covalent immobilization of biocomponents ensures stability, specificity, and long-term performance, addressing limitations of noncovalent methods. Advances in fabrication, such as laser-assisted reduction, enable scalable and cost-effective production of conductive graphene-based electrodes. Covalent functionalization techniques, like carbodiimide coupling and click chemistry, facilitate integration with bioreceptors, leading to highly selective biosensors. Emerging approaches, including inkjet printing of graphene-based inks onto eco-friendly substrates, promise sustainable and portable diagnostic devices. These advances support biosensors aligned with modern and sustainable technologies. Future efforts must focus on scalable production, improved multiplexing, and environmental sustainability to fully harness the potential of graphene derivatives in electrochemical biosensors., This work was supported by the ERDF/ESF project TECHSCALE (grant no. CZ.02.01.01/00/22_008/0004587) and ERDF/ESF project “Interdisciplinary Approaches to the Prevention and Diagnosis of Viral Diseases” (grant no. CZ.02.01.01/00/23_021/0008856). The authors also acknowledge financial support from the European Union through the REFRESH project—Research Excellence for Region Sustainability and High-tech Industries (grant no. CZ.10.03.01/00/22_003/0000048), funded via the Operational Programme Just Transition. Additional funding was provided by the European Union's Horizon Europe research and innovation programme (project GRADERINK no. 101137959). This work has received also funding from the European Union's Horizon Europe research and innovation program (SUSNANO) under grant agreement no. 101059266 and from the European Union's Horizon Europe – the Framework Programme for Research and Innovation (2021–2027) under grant agreement No 101120706 (2D-BioPAD). The views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, Grant CEX2021-001214-S, funded by MCIU/AEI/10.13039.501100011033. We acknowledge Departament de Recerca i Universitats of Generalitat de Catalunya for the grant 2021 SGR 01464. We also acknowledge grant PID2021-124795NB-I00 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF/EU”., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

2D material-based sensing technology innovation roadmap for biomedical applications

  • Tsolakis, Apostolos C.
  • Zadrozny, Thomas
  • Bakandritsos, Aristides
  • Rosetti, Marianna
  • Merkoçi, Arben
  • Bouchiat, Vincent
  • Angelakeris, Makis
  • Kumar, Sandeep
  • Toulmé, Jean Jacques
  • Folas, Aristotelis
  • Hempel, Felix
  • Singh, Chandan
  • Tarasov, Alexey
  • Batsouli, Despoina
  • Tsiotos, Spyros
  • Yannopoulos, Spyros N.
  • Marcano, Diana
  • Deligkiozi, Ioanna
  • Izquierdo Bote, Daniel
  • González García, María Begoña
  • Fanjul Bolado, Pablo
  • Bosch Serrano, Cristian
Two-dimensional materials (2MD) have emerged as a transformative platform for biomedical sensing owing to their unique properties. Over the past decade, 2DM, such as graphene and MXenes have enabled sensing concepts with the potential to surpass the sensitivity, speed, and miniaturization limits of conventional technologies. When combined with other innovative materials such as aptamers or magnetic nanoparticles (MNPs), a range of components can be developed. From electrochemical electrodes and field effect transistor channels to conductive inks and triboelectric nanogenerators, these components offer a variety of biomedical applications that have the potential to revolutionize healthcare. This Roadmap reviews the current state of 2DM-based biomedical sensing within four EU-funded Horizon Europe projects under the Graphene Flagship, identifies key scientific and technological barriers, and outlines priority research directions for the short (2027) and mid-term (2030) future. The analysis focuses on the materials, various components comprising these materials, and several biomedical applications that are currently being researched within the overall biomedical focus of the Graphene Flagship Initiative. By consolidating expert perspectives from the four consortia, this roadmap aims to guide coordinated efforts to accelerate the transition of 2DM from laboratory demonstrations to robust, scalable, and impactful biomedical sensing technologies., This study was funded by the European Union under GA No. 101120706 (2D-BioPAD), GA 101119473 (MUNASET), GA 101120832 (GRAPHERGIA), and GA 101135965 (SAFARI). However, the views and opinions expressed are those of the authors only and do not necessarily reflect those of the European Union or CNECT. Neither the European Union nor the granting authority can be held responsible for them. The authors would like to thank the Fraunhofer ISI team, particularly Dr Henning Döscher and Dr Thomas Reiß, for their guidance in adopting and implementing the 3I methodology for drafting this roadmap., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Quantum-Capacitance Biosensing Enables Real-Time Monitoring of Naxitamab for Therapeutic Response Stratification in Neuroblastoma

  • Bruno, Andy
  • Álvarez-Diduk, Ruslan
  • Lara, Paula
  • Maroli, Gabriel
  • Larrosa, Cristina
  • López-Miralles, Sandra
  • Mora, Jaume
  • Rodríguez-Hernández, Carlos J.
  • Merkoçi, Arben
Neuroblastoma, a leading cause of cancer-related mortality in early childhood, relies on anti-GD2 immunotherapy, whose efficacy is critically dependent on systemic drug exposure that remains largely unmonitored in real time, limiting treatment optimization and early response assessment. Here, a first-in-class, label-free electrochemical biosensing platform is reported for the direct quantification of naxitamab in patient-derived samples. The system is based on a laser-assisted reduced graphene oxide-gold nanoparticle (rGO@AuNPs) nanocomposite, enabling ultrasensitive detection through quantum capacitance modulation arising from perturbations in the electronic density of states of graphene upon biomolecular recognition. Laser-assisted fabrication yields nanostructured electrodes with enhanced surface area and conductivity, promoting stable antibody immobilization and reproducible signal transduction. The platform operates in the femtomolar regime, with a linear response between 25 and 300 fM, high specificity against relevant interferents, and robust performance in diluted human serum. A single-point calibration strategy enables accurate quantification while compensating for device variability. Application to retrospective clinical samples reveals distinct post-infusion concentration profiles, enabling early discrimination between responder groups and detection of antidrug antibody development. This work establishes quantum-capacitance biosensing as a generalizable strategy for real-time monitoring of therapeutic antibodies in precision oncology., This study was supported by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme (Grant CEX2021-001214-S), funded by MCIN/AEI/10.13039.501100011033. Project AC21_2/00044, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union Next Generation EU/PRTR (GLEBioassay). The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. This project has received funding from the European Union's Horizon Europe – the Framework Programme for Research and Innovation (2021–2027) under grant agreement No 101120706., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Harnessing Bioluminescent Bacteria to Develop an Enzymatic-free Enzyme-linked immunosorbent assay for the Detection of Clinically Relevant Biomarkers

  • Hu, Liming|||0000-0002-8666-9287
  • Rossetti, Marianna|||0000-0001-5711-1287
  • Bergua Canudo, José Francisco|||0000-0002-5969-193X
  • Parolo, Claudio|||0000-0001-9481-4408
  • Álvarez Diduk, Ruslan|||0000-0002-9876-1574
  • Rivas, Lourdes|||0000-0002-1510-5927
  • Idili, Andrea|||0000-0002-6004-270X
  • Merkoçi, Arben|||0000-0003-2486-8085
Enzyme-linked immunosorbent assay (ELISA) is the gold standard technique for measuring protein biomarkers due to its high sensitivity, specificity, and throughput. Despite its success, continuous advancements in ELISA and immunoassay formats are crucial to meet evolving global challenges and to address new analytical needs in diverse applications. To expand the capabilities and applications of immunoassays, we introduce a novel ELISA-like assay that we call Bioluminescent-bacteria-linked immunosorbent assay (BBLISA). BBLISA is an enzyme-free assay that utilizes the inner filter effect between the bioluminescent bacteriaAllivibrio fischeriand metallic nanoparticles (gold nanoparticles and gold iridium oxide nanoflowers) as molecular absorbers. Functionalizing these nanoparticles with antibodies induces their accumulation in wells upon binding to molecular targets, forming the classical immune-sandwich complex. Thanks to their ability to adsorb the light emitted by the bacteria, the nanoparticles can suppress the bioluminescence signal, allowing the rapid quantification of the target. To demonstrate the bioanalytical properties of the novel immunoassay platform, as a proof of principle, we detected two clinically relevant biomarkers (human immunoglobulin G and SARS-CoV-2 nucleoprotein) in human serum, achieving the same sensitivity and precision as the classic ELISA. We believe that BBLISA can be a promising alternative to the standard ELISA techniques, offering potential advancements in biomarker detection and analysis by combining nanomaterials with a low-cost, portable bioluminescent platform.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reduced graphene oxide electrodes meet lateral flow assays, A promising path to advanced point-of-care diagnostics

  • Calucho, Enric|||0000-0002-6024-765X
  • Álvarez Diduk, Ruslan|||0000-0002-9876-1574
  • Piper, Andrew|||0000-0002-1208-8009
  • Rossetti, Marianna|||0000-0001-5711-1287
  • Nevanen, Tarja K.
  • Merkoçi, Arben|||0000-0003-2486-8085
Research in electrochemical detection in lateral flow assays (LFAs) has gained significant momentum in recent years. The primary impetus for this surge in interest is the pursuit of achieving lower limits of detection, especially given that LFAs are the most widely employed point-of-care biosensors. Conventionally, the strategy for merging electrochemistry and LFAs has centered on the superposition of screen-printed electrodes onto nitrocellulose substrates during LFA fabrication. Nevertheless, this approach poses substantial limitations regarding scalability. In response, we have developed a novel method for the complete integration of reduced graphene oxide (rGO) electrodes into LFA strips. We employed a CO laser to concurrently reduce graphene oxide and pattern nitrocellulose, exposing its backing to create connection sites impervious to sample leakage. Subsequently, rGO and nitrocellulose were juxtaposed and introduced into a roll-to-roll system using a wax printer. The exerted pressure facilitated the transfer of rGO onto the nitrocellulose. We systematically evaluated several electrochemical strategies to harness the synergy between rGO and LFAs. While certain challenges persist, our rGO transfer technology presents compelling potential for setting a new standard in electrochemical LFA fabrication.